Stephanie Lewis: Unscripted

MES Life Safety has offloaded its alleged PFAS liabilities to a third party, a strategic move to de-risk its finances and focus on its core mission.

A new report reveals a paradoxical trend: plaintiff firms are filing fewer securities lawsuits but securing record-breaking, multi-million dollar settlements.

Aesthetics firm Evolus reports its first profitable quarter and robust growth, banking on new products and international markets to defy industry slowdowns.

Operational failures at a key Texas plant and a sudden drop in chlorine demand force chemical giant Olin Corp. to drastically cut its Q4 earnings forecast.

Schuman Cheese partners with Wyke Farms, bringing a celebrated British cheddar known for its rich heritage and pioneering sustainability to American consumers.

Private equity's latest move signals a major consolidation push in the fragmented EH&S sector, leveraging tech and services to build a safety powerhouse.

Vantage Group's acquisition of fuel and de-icing specialists FSM and AvEnergy signals a major move to control the unseen backbone of air travel.

Twin Valley's CEO takes the helm at NTCA, facing policy hurdles, a CEO transition, and an ambitious goal to connect all of rural America by 2030.

MasterCraft's all-new X22 packs flagship technology, unmatched power, and refined luxury into a 22-foot frame, setting a new benchmark for its class.

The investment giant's new podcast season tackles the energy trilemma, exploring AI's power thirst, the return of nuclear, and fossil fuel's role.

858 Therapeutics' novel PARG inhibitor offers new hope for patients with a deadly, drug-resistant form of ovarian cancer, accelerating its path to approval.

A new clinical benchmark published in a Nature journal reveals a Chinese AI is the safest and most effective, challenging Silicon Valley's dominance.

Dexcel Pharma USA acquires Zubsolv®, a key opioid addiction therapy, signaling a major strategic shift into the branded drug market in the U.S.

The newly formed food tech giant will outline its strategic priorities, with investors closely watching for synergy updates and future growth plans.

Beauty giant L'Oréal partners with LED innovator iSMART, signaling a new era of professional-grade light therapy devices for your daily routine.

With a $30.9M rights offering, Rare Element Resources aims to advance its Wyoming project, a key piece in America's race for rare earth independence.

UBC's strategic acquisition of Evidinno creates a new powerhouse in biopharma evidence, combining global scale with AI-driven health economic insights.

Unveiled at CES 2026, the Palette 300 challenges the 3D printing market with a radical design that promises high-speed, multi-material prints with near-zero waste.

SUI Group's appointment of former CFTC Commissioner Brian Quintenz signals a strategic push for regulatory credibility and institutional crypto adoption.

With billions from Intel and Joby Aviation, Ohio is using CES 2026 to prove it's the new epicenter for advanced manufacturing, AI, and mobility.